Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd (DLCL) is a micro-cap Healthcare Services company valued at ₹6 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move

Dr Lalchandani Labs Ltd last traded at ₹7.49, sharply up 7.15% on the day.

Recent developments

On 2026-03-31, the company reported its latest quarter results, showing a net loss of ₹0 crore, a swing from a net profit of ₹0 crore in the same quarter a year earlier. There are no recent developments reported in the FACTS.

Financial performance

The company's annual revenue fell 5.8% year-over-year, while the latest quarter revenue dropped 8.6% compared to the same quarter a year earlier. Annual net profit remained at ₹0 crore, with the latest quarter showing a swing from a net profit of ₹0 crore to a loss of ₹0 crore. The net profit margin narrowed 7.8 percentage points to 1.5%, and return on equity and return on capital employed remained at 0.5% and 0.7% respectively.

Valuation multiples

The stock trades at 107.0 times earnings, 0.48 times book value.

Things to watch

The company has reported an annual net profit of ₹0 crore, which has declined by -85.7% year-over-year. The net profit margin has narrowed 7.8 percentage points to 1.5%. The stock is 70.5% below its 52-week high.

Where it stands

The company's business has shown a decline in revenue and profitability, with the latest quarter showing a net loss of ₹0 crore. The stock is 70.5% below its 52-week high, and the net profit margin has narrowed significantly.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.